MUMariia O. Usenko

Mariia O. Usenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mariia O. Usenko has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Probing the Molecular Basis of Aminoacyl‐Adenylate Affinity With Mycobacterium tuberculosis Leucyl‐tRNA Synthetase Employing Molecular Dynamics, Umbrella Sampling Simulations and Site‐Directed Mutagenesis

    by Galyna P. Volynets, Olga I. Gudzera, Mariia O. Usenko, Oksana B. Gorbatiuk, Volodymyr G. Bdzhola, Igor M. Kotey, Anatoliy O. Balanda, Andrii O. Prykhod'KO, Sergiy S. Lukashov, Oleksiy A. Chuk, et al.

    Leucyl‐tRNA synthetase (LeuRS) is clinically validated molecular target for antibiotic development. Recently, we have reported several classes of small‐molecular inhibitors targeting aminoacyl‐adenylate binding site of Mycobacterium tuberculosis LeuRS with antibacterial activity. In this work, we performed in silico site‐directed mutagenesis of M. tuberculosis LeuRS synthetic site in order to identify the most critical amino acid residues for the interaction with substrate and prove binding modes of inhibitors. We carried out 20‐ns molecular dynamics (MD) simulations and used umbrella sampling (US) method for the calculation of the binding free energy (ΔGb) of leucyl‐adenylate with wild‐type and mutated forms of LeuRS. According to molecular modeling results, it was found that His89, Tyr93, and Glu660 are essential amino acid residues both for aminoacyl‐adenylate affinity and hydrogen bond formation. We have selected His89 for experimental site‐directed mutagenesis since according to our previous molecular docking results this amino acid residue was predicted to be important for inhibitor interaction in adenine‐binding region. We obtained recombinant mutant M. tuberculosis LeuRS H89A. Using aminoacylation assay we have found that the mutation of His89 to Ala in the active site of M. tuberculosis LeuRS results in significant decrease of inhibitory activity for compounds belonging to three different chemical classes—3‐phenyl‐5‐(1‐phenyl‐1H‐[1,2,3]triazol‐4‐yl)‐[1,2,4]oxadiazoles, N‐benzylidene‐N′‐thiazol‐2‐yl‐hydrazines, and 1‐oxo‐1H‐isothiochromene‐3‐carboxylic acid (4‐phenyl‐thiazol‐2‐yl)‐amide derivatives. Therefore, the interaction with His89 should be taken into account during further M. tuberculosis LeuRS inhibitors development and optimization.


  • Open Access

    Характеризація очищеної рекомбінантної субодиниці В дифтерійного токсину як інструмента його дослідження

    by К.ю. Манойлов, O.B. Gorbatiuk, М.о. Усенко, О.я. Шатурський, T.O. Борисова, Д.в. Колибо, С.в. Комісаренко, K.Yu. Manoilov, O.Ya. Shatursky

    Очищення препаратів рекомбінантної субодиниці В (SbB) дифтерійного токсину (DT), синтезованої в цитоплазмі, периплазмі і нерозчинних тільцях включення клітин Escherichia coli, проведене за допомогою металоафінної хроматографії після руйнування бактеріальної ДНК та клітинної стінки ензимами, дало можливість позбутися домішок ендогенних пороформуючих протеїнів. Показано, що рекомбінантні похід ні DT, SbB та CRM197 мають однакову спорідненість з рецепторами чутливих та резистентних до токсину клітин ліній Vero і L929 відповідно. Прикладання позитивного потенціалу з боку додавання SbВ (0,3 мкг/мл) до фосфатидилетаноламінвмісної бішарової мембрани у розчині 1 M KCl (pH 4,8) призводить до утворен ня потенціалозалежних іонних каналів з провідністю 20 пСм, як показано у класичних дослідженнях природ ного DT. За даними порівняльного аналізу, характеристики утворення і функціону вання каналів DT найкраще відтворюються SbB, синтезованою в неактивній формі у вигляді тілець включення, та ренатурованою in vitro.

  • Identification of Dual-Targeted Mycobacterium Tuberculosis Aminoacyl-tRNA Synthetase Inhibitors Using Machine Learning

    by Galyna P Volynets, Mariia O Usenko, Olga I Gudzera, Segiy A Starosyla, Anatoliy O Balanda, Anatolii R Syniugin, Oksana B Gorbatiuk, Andrii O Prykhod'Ko, Volodymyr G Bdzhola, Sergiy M Yarmoluk, et al.

    Background: The most serious challenge in the treatment of tuberculosis is the multidrug resistance of Mycobacterium tuberculosis to existing antibiotics. As a strategy to overcome resistance we us... Graphical abstract


  • Production of recombinant human apoptosis signal-regulating kinase 1 (ASK1) in Escherichia coli

    by Galyna P. Volynets, Oksana B. Gorbatiuk, Oleksandr P. Kukharenko, Mariya O. Usenko, Sergiy M. Yarmoluk


  • Open Access

    Recombinant Staphylococcal protein A with cysteine residue for preparation of affinity chromatography stationary phase and immunosensor applications

    by O. B. Gorbatiuk, A. O. Bakhmachuk, L. V. Dubey, M. O. Usenko, D. M. Irodov, O. V. Okunev, O. M. Kostenko, A. E. Rachkov, V. A. Kordium

    Aim. Engineering of recombinant Staphylococcal protein A with cysteine residue (SPA-Cys) for preparation of affinity chromatography stationary phase and formation of bioselective element of immunosensor. Methods. DNA sequences encoding IgG-binding region of SPA, His-tag and cysteine were genetically fused and expressed in E. coli. SPA-Cys was immobilized on maleimide-functionalized silica beads for affinity chromatography stationary phase preparation and on a gold sensor surface as a bioselective element of immunosensor. Results. SPA-Cys was expressed at a high-level in a soluble form. The target protein was purified and showed a high IgG-binding activity. The capacity of the obtained SPA-Cys-based affinity chromatography stationary phase was 10–12 mg of IgG /ml. The purity of eluted IgG was more than 95 % in one-step purification procedure. The developed SPA-Cys-based bioselective element of immunosensor selectively interacted with human IgG and did not interact with the control proteins. Conclusions. The recombinant Staphylococcal protein A with cysteine residue was successfully used for the preparation of affinity chromatography stationary phase and formation of the bioselective element of immunosensor.\u